228 related articles for article (PubMed ID: 1348537)
21. Endogenous dynorphin modulates calcium-mediated antinociception in mice.
Smith FL; Dewey WL
Pharmacol Biochem Behav; 1993 Jun; 45(2):383-91. PubMed ID: 8101006
[TBL] [Abstract][Full Text] [Related]
22. Confluence of antianalgesic action of diverse agents through brain interleukin(1beta) in mice.
Rady JJ; Fujimoto JM
J Pharmacol Exp Ther; 2001 Nov; 299(2):659-65. PubMed ID: 11602679
[TBL] [Abstract][Full Text] [Related]
23. Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.
Welch SP
J Pharmacol Exp Ther; 1993 May; 265(2):633-40. PubMed ID: 8388455
[TBL] [Abstract][Full Text] [Related]
24. Antagonism of morphine antinociception by intrathecally administered corticotropin-releasing factor in mice.
Song ZH; Takemori AE
J Pharmacol Exp Ther; 1991 Mar; 256(3):909-12. PubMed ID: 1848633
[TBL] [Abstract][Full Text] [Related]
25. Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice.
Arts KS; Holmes BB; Fujimoto JM
J Pharmacol Exp Ther; 1991 Mar; 256(3):890-6. PubMed ID: 2005587
[TBL] [Abstract][Full Text] [Related]
26. Spinal dynorphin A (1-17): possible mediator of antianalgesic action.
Fujimoto JM; Arts KS; Rady JJ; Tseng LF
Neuropharmacology; 1990 Jul; 29(7):609-17. PubMed ID: 1974711
[TBL] [Abstract][Full Text] [Related]
27. Differential mechanisms mediating beta-endorphin- and morphine-induced analgesia in mice.
Suh HH; Fujimoto JM; Tseng LL
Eur J Pharmacol; 1989 Sep; 168(1):61-70. PubMed ID: 2531093
[TBL] [Abstract][Full Text] [Related]
28. Supraspinal neurotensin-induced antianalgesia in mice is mediated by spinal cholecystokinin.
Holmes BB; Rady JJ; Smith DJ; Fujimoto JM
Jpn J Pharmacol; 1999 Feb; 79(2):141-9. PubMed ID: 10202849
[TBL] [Abstract][Full Text] [Related]
29. Dynorphin-(1-13): antinociceptive action and its effects on morphine analgesia and acute tolerance.
Kishioka S; Morita N; Kitabata Y; Yamanishi T; Miyamoto Y; Ozaki M; Yamamoto H
Jpn J Pharmacol; 1992 Nov; 60(3):197-207. PubMed ID: 1362787
[TBL] [Abstract][Full Text] [Related]
30. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
[TBL] [Abstract][Full Text] [Related]
31. Antianalgesic action of nociceptin originating in the brain is mediated by spinal prostaglandin E(2) in mice.
Rady JJ; Campbell WB; Fujimoto JM
J Pharmacol Exp Ther; 2001 Jan; 296(1):7-14. PubMed ID: 11123356
[TBL] [Abstract][Full Text] [Related]
32. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
33. Characterization of dynorphin A-induced antinociception at spinal level.
Spampinato S; Candeletti S
Eur J Pharmacol; 1985 Mar; 110(1):21-30. PubMed ID: 2861098
[TBL] [Abstract][Full Text] [Related]
34. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
Gairin JE; Gout R; Meunier JC; Cros J
J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
[TBL] [Abstract][Full Text] [Related]
35. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
[TBL] [Abstract][Full Text] [Related]
36. Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.
Lux F; Welch SP; Brase DA; Dewey WL
J Pharmacol Exp Ther; 1988 Aug; 246(2):500-7. PubMed ID: 3136242
[TBL] [Abstract][Full Text] [Related]
37. Evidence that endogenous opioids mediate the antinociceptive effects of intrathecally administered calcium in mice.
Smith FL; Dewey WL
J Pharmacol Exp Ther; 1992 Sep; 262(3):995-1003. PubMed ID: 1326632
[TBL] [Abstract][Full Text] [Related]
38. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test.
Horan P; Taylor J; Yamamura HI; Porreca F
J Pharmacol Exp Ther; 1992 Mar; 260(3):1237-43. PubMed ID: 1312164
[TBL] [Abstract][Full Text] [Related]
39. Modulation of acute morphine tolerance by corticotropin-releasing factor and dynorphin A in the mouse spinal cord.
Song SH; Takemori AE
Life Sci; 1992; 51(2):107-11. PubMed ID: 1352026
[TBL] [Abstract][Full Text] [Related]
40. Intrathecal morphine-3-glucuronide-induced nociceptive behavior via Delta-2 opioid receptors in the spinal cord.
Komatsu T; Katsuyama S; Nagase H; Mizoguchi H; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Pharmacol Biochem Behav; 2016 Jan; 140():68-74. PubMed ID: 26476133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]